SM
TNDM icon

Sciencast Management’s Tandem Diabetes Care TNDM Stock Holding History

Sciencast Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$218K Buy
+3,276
New +$269K 0.05% 352
2020
Q4 		– Sell
-3,450
Closed -$401K – 613
2020
Q3 		$401K Buy
+3,450
New +$362K 0.15% 226

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Sciencast Management's TNDM Position: Q2 2022 in Review

Sciencast Management opened a new position in Tandem Diabetes Care (TNDM) in Q2 2022: 3,276 shares worth $218K. The stake represents 0.05% of the portfolio and ranks #352 among its holdings. This is a return to the name: Sciencast Management previously reported a position in TNDM as recently as Q3 2020.

Sciencast Management first reported a position in TNDM in Q3 2020 and has held it in 2 quarters since. The position peaked at $401K in Q3 2020. 330 funds tracked by Wall St. Rank hold TNDM as of Q2 2022.

  • Sciencast Management held 3,276 shares of Tandem Diabetes Care worth $218K as of Q2 2022.
  • Tandem Diabetes Care was a new Sciencast Management position in Q2 2022.
  • Tandem Diabetes Care made up 0.05% of Sciencast Management's portfolio in Q2 2022, its #352 holding.
  • Sciencast Management first reported a position in Tandem Diabetes Care in Q3 2020 and has held it in 2 quarters since.
  • Sciencast Management's Tandem Diabetes Care position peaked at $401K in Q3 2020.
  • 330 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2022.

Based on Sciencast Management's 13F filing for Q2 2022, filed 3 Aug 2022.